Stroke in the Middle-East and North Africa: A 2-year prospective observational study of intravenous thrombolysis treatment in the region. Results from the SITS-MENA Registry.


Journal

International journal of stroke : official journal of the International Stroke Society
ISSN: 1747-4949
Titre abrégé: Int J Stroke
Pays: United States
ID NLM: 101274068

Informations de publication

Date de publication:
12 2020
Historique:
pubmed: 9 10 2019
medline: 26 10 2021
entrez: 10 10 2019
Statut: ppublish

Résumé

Intravenous thrombolysis for acute ischemic stroke in the Middle-East and North African (MENA) countries is still confined to the main urban and university hospitals. This was a prospective observational study to examine outcomes of intravenous thrombolysis-treated stroke patients in the MENA region compared to the non-MENA stroke cohort in the SITS International Registry. Of 32,160 patients with ischemic stroke registered using the SITS intravenous thrombolysis protocol between June 2014 and May 2016, 500 (1.6%) were recruited in MENA. Compared to non-MENA (all Intravenous thrombolysis patients in MENA were younger, had more severe strokes and more often diabetes. Although stroke severity was higher in MENA, short-term functional independency and mortality were not worse compared to non-MENA, which could partly be explained by younger age and shorter OTT in MENA. Decreasing the burden of stroke in this young population should be prioritized.

Sections du résumé

BACKGROUND AND METHODS
Intravenous thrombolysis for acute ischemic stroke in the Middle-East and North African (MENA) countries is still confined to the main urban and university hospitals. This was a prospective observational study to examine outcomes of intravenous thrombolysis-treated stroke patients in the MENA region compared to the non-MENA stroke cohort in the SITS International Registry.
RESULTS
Of 32,160 patients with ischemic stroke registered using the SITS intravenous thrombolysis protocol between June 2014 and May 2016, 500 (1.6%) were recruited in MENA. Compared to non-MENA (all
CONCLUSIONS
Intravenous thrombolysis patients in MENA were younger, had more severe strokes and more often diabetes. Although stroke severity was higher in MENA, short-term functional independency and mortality were not worse compared to non-MENA, which could partly be explained by younger age and shorter OTT in MENA. Decreasing the burden of stroke in this young population should be prioritized.

Identifiants

pubmed: 31594533
doi: 10.1177/1747493019874729
doi:

Substances chimiques

Fibrinolytic Agents 0
Tissue Plasminogen Activator EC 3.4.21.68

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

980-987

Auteurs

S Al-Rukn (S)

Department of Neurology, 62743Rashid Hospital - Dubai Health Authority, Dubai, United Arab Emirates.

M Mazya (M)

Department of Neurology, 59562Karolinska University Hospital, Stockholm, Sweden.
Department of Clinical Neurosciences, 27106Karolinska Institutet, Stockholm, Sweden.

N Akhtar (N)

62849Hamad General Hospital, Section of Neurology, Doha, Qatar.

H Hashim (H)

Department of Neurology, 62743Rashid Hospital - Dubai Health Authority, Dubai, United Arab Emirates.

B Mansouri (B)

Department of Neurology, Imam Husain Hospital, Tehran, Iran.

B Faouzi (B)

Department of Neurology, Hassan II University Hospital, Fez, Morocco.

H Aref (H)

68791Ain Shams University, Stroke Unit, Cairo, Egypt.

H Abdulrahman (H)

Department of Neurology, 48168King Abdulaziz Medical City, Riyadh, Saudi Arabia.

S Kesraoui (S)

Department of Neurology, CHU de Blida - Hôpital Franz Fanon, Blida, Algeria.

F Hentati (F)

Department of Neurology, Mongi Ben Hamida National Institute of Neurology, Tunis, Tunisia.

S Gebelly (S)

Faculty of Medical Sciences - Lebanese University, Neurology Division, Hadath, Lebanon.

N Ahmed (N)

Department of Neurology, 59562Karolinska University Hospital, Stockholm, Sweden.
Department of Clinical Neurosciences, 27106Karolinska Institutet, Stockholm, Sweden.

N Wahlgren (N)

Department of Clinical Neurosciences, 27106Karolinska Institutet, Stockholm, Sweden.

F Abd-Allah (F)

Department of Neurology, Cairo University, Cairo, Egypt.

M Almekhlafi (M)

Department of Neurology, 37848King Abdulaziz University, Jeddah, Saudi Arabia.

T Moreira (T)

Department of Neurology, 59562Karolinska University Hospital, Stockholm, Sweden.
Department of Clinical Neurosciences, 27106Karolinska Institutet, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH